ASX - By Stock
|
CYP |
Re:
Ann: Cynata Enters into a New Strategic Partnership with Fujifilm
|
|
berad
|
249 |
55K |
17 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
249
|
55K
|
17
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Enters into a New Strategic Partnership with Fujifilm
|
|
berad
|
249 |
55K |
22 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
249
|
55K
|
22
|
|
ASX - By Stock
|
CYP |
Re:
Ann: New Study to Investigate the High Potency of Cymerus MSCs
|
|
berad
|
65 |
15K |
17 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
65
|
15K
|
17
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
berad
|
219 |
43K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
219
|
43K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
berad
|
219 |
43K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
219
|
43K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
berad
|
219 |
43K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
219
|
43K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
berad
|
219 |
43K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
219
|
43K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
berad
|
219 |
43K |
7 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
219
|
43K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
berad
|
133 |
28K |
7 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
133
|
28K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
berad
|
133 |
28K |
6 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
133
|
28K
|
6
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
berad
|
345 |
93K |
7 |
01/09/20 |
01/09/20 |
Charts
|
345
|
93K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Scheduled FDA Advisory Committee Meeting
|
|
berad
|
176 |
88K |
6 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
176
|
88K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
berad
|
495 |
109K |
4 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
495
|
109K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
berad
|
495 |
109K |
15 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
495
|
109K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
berad
|
495 |
109K |
1 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
495
|
109K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
berad
|
495 |
109K |
30 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
495
|
109K
|
30
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
berad
|
23K |
13M |
31 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
23K
|
13M
|
31
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
berad
|
23K |
13M |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
berad
|
23K |
13M |
8 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
berad
|
274 |
76K |
5 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
274
|
76K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
berad
|
274 |
76K |
7 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
274
|
76K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
berad
|
149 |
44K |
8 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
149
|
44K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Monday Opening Price
|
|
berad
|
312 |
156K |
5 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
312
|
156K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
berad
|
149 |
44K |
1 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
149
|
44K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
berad
|
149 |
44K |
4 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
149
|
44K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
berad
|
149 |
44K |
14 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
149
|
44K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
berad
|
149 |
44K |
16 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
149
|
44K
|
16
|
|
ASX - By Stock
|
CYP |
Re:
Hopelessly inopportunic
|
|
berad
|
7 |
1.8K |
4 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
7
|
1.8K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
berad
|
133 |
28K |
5 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
133
|
28K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
berad
|
133 |
28K |
10 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
133
|
28K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
berad
|
133 |
28K |
20 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
133
|
28K
|
20
|
|
ASX - By Stock
|
CYP |
Re:
Cynata has manufacturing solution for new covd treatments
|
|
berad
|
78 |
24K |
12 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
78
|
24K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
berad
|
507 |
1.5M |
15 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
507
|
1.5M
|
15
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
berad
|
507 |
1.5M |
12 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
507
|
1.5M
|
12
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
berad
|
507 |
1.5M |
23 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
507
|
1.5M
|
23
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
berad
|
507 |
1.5M |
8 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
507
|
1.5M
|
8
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
berad
|
507 |
1.5M |
10 |
02/02/20 |
02/02/20 |
ASX - By Stock
|
507
|
1.5M
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata & Sumitomo Withdraw from Acquisition Discussions
|
|
berad
|
80 |
37K |
13 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
80
|
37K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
berad
|
97 |
41K |
2 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
97
|
41K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata confirms receipt of indicative non-binding proposal
|
|
berad
|
335 |
211K |
9 |
19/07/19 |
19/07/19 |
ASX - By Stock
|
335
|
211K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
berad
|
56 |
31K |
1 |
17/07/19 |
17/07/19 |
ASX - By Stock
|
56
|
31K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
berad
|
56 |
31K |
9 |
17/07/19 |
17/07/19 |
ASX - By Stock
|
56
|
31K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: June 2019 Quarterly Report
|
|
berad
|
25 |
8.7K |
12 |
04/07/19 |
04/07/19 |
ASX - By Stock
|
25
|
8.7K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
SHAW N PARTNERS target again 2.50.
|
|
berad
|
17 |
8.0K |
8 |
25/06/19 |
25/06/19 |
ASX - By Stock
|
17
|
8.0K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Strengthens Board & Executive Management Team
|
|
berad
|
28 |
13K |
7 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
28
|
13K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
berad
|
258 |
85K |
5 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
258
|
85K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
berad
|
258 |
85K |
2 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
258
|
85K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
berad
|
258 |
85K |
0 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
258
|
85K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
berad
|
258 |
85K |
3 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
258
|
85K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Extends FUJIFILM Licence Option in GvHD
|
|
berad
|
258 |
85K |
9 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
258
|
85K
|
9
|
|